Compare First Citizens BancShares Inc (FCNCA) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Citizens BancShares Inc vs State Street SPDR S&P Biotech ETF — how do they compare? First Citizens BancShares Inc trades at $2,249.28 (market cap $25.04B), while State Street SPDR S&P Biotech ETF trades at $157.99. The key difference: First Citizens BancShares Inc pays a 0.37% dividend while State Street SPDR S&P Biotech ETF pays none, and First Citizens BancShares Inc is trading nearer its 52-week high, State Street SPDR S&P Biotech ETF nearer its low. Which is the better fit depends on your goals.
| FCNCA | XBI | |
|---|---|---|
Market Cap | $25.04B | — |
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $2.25K | $164.28 |
52-Week Low | $1.64K | $86.92 |
Dividend Yield | 0.37% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
